ImmunityBio Inc XNAS: IBRX

Download real time

6.92 0.44 (6.79%)

New 52W High in past week

95.6M

XNAS Volume

High volume+gain today

XNAS 21 Jan, 2026 4:30 PM (EST)

-

Beta 1Year

Very Low volatility

Regulatory Tailwinds

ImmunityBio rises on Tuesday as FDA clears approval path for its bladder cancer drug, ANKTIVA See details

ImmunityBio Inc RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

ImmunityBio Inc technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis